Summary
OK432, one of the immunomodulators used for cancer treatment in Japan was examined for its effects on murine myocarditis due to encephalomyocarditis (EMC) virus. The survival rate of mice administered with 1 KE of OK432 intraperitoneally every other day starting 2 days before viral inoculation was significantly higher than that of the control mice administered virus alone on days 10–21 (16/ 20 vs. 4/20, p < 0.001), and the viral titer in the heart, the heart weight/body weight ratio, and the scores for myocardial inflammation and necrosis were significantly lower. The natural killer (NK) cell activity and interferon (IFN) titer on day 1 after infection were increased in comparison with the control group (NK cell activity: 51.1 vs. 37.9%, p < 0.05. IFN: 1205 vs 512 U/ml), and the cytotoxicity of peritoneal macrophages was increased (50.6 vs. 29.1%). Thus, OK432 given before viral inoculation significantly improved survival and reduced both the viral titer in the heart and myocardial damage in this experimental model of acute EMC viral myocarditis. Accordingly, the stimulation of the host immunologic response by OK432 may be important for elimination of virus of the heart.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Okamoto H, Shoin S. Studies on the anticancer and streptolysin S-forming abilities of hemolytic streptococci, a review.Jpn J Microbiol 1967;11:323–336.
Uchida A, Hoshino T. Clinical studies on cell-mediated immunity in patients with malignant disease. 1, Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responses in vitro.Cancer 1980;45:476–483.
Sakurai Y, Tsukagoshi S, Satho H, et al. Tumor inhibitory effect of a streptococcal preparation (NSC-B116209).Cancer Chemother Rep 1972;56:9–17.
Watanabe T, Saito H. Protection of mice against herpes simplex virus infection by aLactobacillus cassi preparation (LC 9018) in combination with inactivated viral antigen.Microbiol Immunol 1986;30:111–122.
Asabe Y, Takei I, Maruyama T, et al. Inhibition of development of EMC virus induced diabetes mellitus by OK432. InAbstracts of the 13th International Diabetes Federation (Tokyo) 1987;35:3.
Adamson TC, Frisman DM, Howell FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren’s syndrome using monoclonal antibodies.J Immunol 1983; 130:203–208.
McManus BM, Gauntt CJ, Cassling RS. Immunopathologic basis of myocardial injury. In: Waller B, ed,Contemporary issues in cardiovascular pathology. Cardiovasc Clin 1987;18:163–184.
Maishch B. Immunologic regulator and effector function in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy.Basic Res Cardiol 1986;81: 217–242.
Lodge PA, Herzum M, Olszewski J, Huber SA. Coxsackie-virus B3 myocarditis acute and chronic forms of the disease caused by different immunopathogenic mechanisms.Am J Pathol 1987;128:455–463.
Monrad ES, Matsumori A, Murphy JC, et al. Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus.Circulation 1986;73:1058–1064.
Tomioka N, Kishimoto C, Matsumori A, Kawai C. Effects of prednisolone on acute viral myocarditis in mice.J Am Coll Cardiol 1986;7:868–872.
Kishimoto C, Thorp KA, Abelmann WH. Effects of cyclophosphomide upon murine coxsackievirus B3 myocarditis.Circulation 1988;78:II-348.
Santoli D, Trinchieri G, Lief FS. Cell mediated cytotoxicity against virus infected target cells in humans. Characterization of the effector lymphocyte.J Immunol 1987;121:526–531.
Raymond MW. Regulation of virus infection by natural killer cells, a review.Nat Immun Cell Growth Regul 1986;5:169–199.
Godeny EK, Gauntt CJ. Murine natural killer cells limit coxsackievirus B3 replication.J Immunol 1986;139:913–918.
Habu S, Akamatsu K, Tamaki N, Okumura K. In vivo significance of NK cell on resistance against virus (HSV-1) infection mice.J Immunol 1984;133:2743–2747.
Stanton GJ, Weigent DA, Fleischmann WR Jr., et al. Interferon review.Invest Radiol 1987;22:259–273.
Herbermann RB, Djeu JY, Ortaldo Jr, et al. Role of interferon in augmentation of natural and antibody dependent cell mediated cytotoxicity.Cancer Treat Rep 1978; 62:1893–1896.
Rodda ST, White DO. Cytotoxic macrophages; A rapid non-specific response to viral infection.J Immunol 1976; 117:2067–2072.
Letvin NL, Kauffman RS, Finberg R. An adherent cell lysis virus-infected targets; Characterization, activation, and fine specificity of the cytotoxic cell.J Immunol 1982;129:2396–2401.
Oshimi K, Kano S, Takaku F, Okumura K. Augmentation of mouse natural killer cell activity by streptococcal preparation, OK-432.J Natl Cancer Inst 1980;65:1265–1269.
Wakasugi H, Kasahara T, Minato N, et al. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432. Interferon and interleukin-2 participation in the stimulation with OK-432.J Natl Cancer Inst 1982;69:807–812.
Matsubara S, Suzuki F, Ishida N. Induction of immune interferon in mice treated with a bacterial immunopotentiater, OK-432.Cancer Immunol Immunother 1979;6:41–45.
Murayama T. Antibody dependent cell-mediated cytotoxicity against mouse MM2 tumor cell line by macrophage activated with OK-432.Gann 1984;75:617–624.
Si L, Whiteside TL. Tissue distribution of human NK cells studied with anti-Leu-7 monoclonal antibody.J Immunol 1983;130:2149–2155.
Kasai M, Inamori M, Magai Y, et al. A glycolipid on surface of mouse natural killer cells.Eur J Immunol 1980;10:175–180.
Craighead JE, Steinke J. Diabetes mellitus syndrome in mice infected with encephalomyocarditis virus.Am J Pathol 1971;63:119–132.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yokoyama, T., Kanda, T., Suzuki, T. et al. Preventive effects of OK432 on murine acute myocarditis due to encephalomyocarditis virus. Cardiovasc Drug Ther 5, 471–480 (1991). https://doi.org/10.1007/BF03029772
Issue Date:
DOI: https://doi.org/10.1007/BF03029772